Related Experiment Video
Updated: May 23, 2026
10:37
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
HBV mutations and their clinical significance
T W Lapiński1, J Pogorzelska, R Flisiak
1Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland. twlapinski@wp.pl
Advances in Medical Sciences
|March 21, 2012
Summary
Hepatitis B virus (HBV) vaccination reduced infections, but chronic cases persist. Current therapies like PEG-IFN and nucleoside analogues often fail, leading to drug resistance and potential cancer development.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) vaccination, introduced in 1983, has significantly decreased global HBV infections.
- A substantial population remains with chronic HBV infection, including those infected before vaccination or those for whom the vaccine was ineffective.
Purpose of the Study:
- To address the limitations of current therapies for chronic HBV infection.
- To highlight the challenges posed by existing treatments, including lack of sustained virologic response and the development of drug resistance.
Main Methods:
- Review of current therapeutic strategies for chronic HBV infection.
- Analysis of treatment outcomes associated with PEG-IFN α-2a and nucleotide/nucleoside analogues.
- Examination of mechanisms leading to drug resistance and oncogenic mutations.
Main Results:
- Current therapies, including PEG-IFN α-2a and nucleoside analogues, do not ensure sustained virologic response in most chronically infected individuals.
- Nucleoside analogue treatment can lead to mutations, selection of resistant strains, therapeutic failure, and cross-resistance.
- Selected mutants may possess oncogenic properties, increasing cancer risk.
Conclusions:
- Existing treatments for chronic HBV infection are suboptimal, with significant rates of treatment failure and resistance.
- The emergence of drug-resistant and potentially oncogenic HBV strains necessitates the development of novel therapeutic approaches.
- Further research is crucial to improve treatment efficacy and mitigate long-term risks associated with chronic HBV infection.
More Related Videos
Related Concept Videos
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:18Mutations in Microorganisms
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:39Mutations
Overview